secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protalix BioTherapeutics, Inc. (PLX)
CIK:        0001006281
Form:       8-K
Filed at:   2026-05-21T11:03:16+00:00
Accession:  0001104659-26-064850
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Protalix BioTherapeutics files corporate presentation; no material new information
--------------------------------------------------------------------------------

- Filing reports posting of May 2026 corporate presentation to company website under Item 7.01.
- Exhibit 99.1 contains only title slides with general corporate description and date change from June 2024 to May 2026.
- No financial results, guidance updates, or operational milestones disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006281/000110465926064850/0001104659-26-064850-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006281/000110465926064850/plx-20260521x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-064850

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer